Fléjou, Jean-François
7 papers on CoChatORCID 0000-0002-4971-2434
Most cited papers
- Verified
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., et al. (2013) · PLoS Medicine
Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies
Cited by 1,507
- Verified
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy
Helicobacter pylori-related gastroenterology studiesGastric Cancer Management and Outcomes
Cited by 993
- Verified
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study
André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 683
- Verified
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease
Beaugerie, L., Svrcek, M., Seksik, P., Bouvier, A., Simon, T., Allez, M., Brixi, H., Gornet, J., Altwegg, R., Beau, P., et al. (2013) · Gastroenterology
Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection
Cited by 363
- Verified
MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors
Svrcek, M., Lascols, O., Cohen, R., Collura, A., Jonchère, V., Fléjou, J.-F., Buhard, O., & Duval, A. (2019) · Bulletin du Cancer
Genetic factors in colorectal cancerCancer Immunotherapy and Biomarkers
Cited by 90
- Verified
EGFR- and VEGF(R)-Targeted Small Molecules Show Synergistic Activity in Colorectal Cancer Models Refractory to Combinations of Monoclonal Antibodies
Poindessous, V., Ouaret, D., El Ouadrani, K., Battistella, A., Mégalophonos, V. F., Kamsu-Kom, N., Petitprez, A., Escargueil, A. E., Boudou, P., Dumont, S., et al. (2011) · Clinical Cancer Research
Colorectal Cancer Treatments and StudiesAngiogenesis and VEGF in Cancer
Cited by 55
- Verified
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer
Polack, M., Smit, M. A., van Pelt, G. W., Roodvoets, A. G. H., Meershoek-Klein Kranenbarg, E., Putter, H., Gelderblom, H., Crobach, A. S. L. P., Terpstra, V., Petrushevska, G., et al. (2024) · ESMO Open
Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free